According to OKYO Pharma, OK-101 is the first drug candidate to enroll patients specifically diagnosed with neuropathic ...

This year’s conference, in Chicago, showcased a diverse array of practice-changing data across multiple ophthalmic specialties, including advances in cataract surgery, glaucoma management, and retinal ...

The company will seek a strategic partner to continue development of APX3330, an oral small-molecule inhibitor of Ref-1 for ...

Steven Dell, MD, shares insights from his first SMILE procedure case, detailing key surgical steps and the patient's postoperative experience.

Steven Dell, MD, provides an overview of the SMILE procedure, and shared what motivated him to adopt SMILE procedure in his practice ...

Kamran Riaz, MD, discussed with the Eye Care Network a study on mitomycin intravascular chemoembolization for treating corneal neovascularization. The procedure showed promise, with a 70% success rate ...